Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
eli lilly
fda
indiana blog main
indiana top stories
lasmiditan
life sciences
migraine
2
×
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
teva pharmaceutical
texas blog main
texas top stories
triptans
wisconsin blog main
wisconsin top stories
abalos therapeutics
acetonid
achillion pharmaceuticals
aglios therapeutics
alder biopharmaceutical
alexion pharmaceuticals
allergan
What
drugs
2
×
new
approval
arguments
bails
big
bio
brand
bridgebio
capital
car
class
commercialized
companies
competitors
decades
develop
drug
emerges
fda
firm
grab
headlines
ichnos
invest
life
make
meeting
migraine
millions
neuro
oral
pharmaceutical
potential
roundup
science
tens
therapies
typically
venture
Language
unset
Current search:
migraine
×
drugs
×
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
